HNRNPK and renal cell carcinoma: Furthermore, the detection of cytoplasmic distribution of hnRNP K in IHC analysis appears to be a promising prognostic biomarker to predict metastatic RCC and to identify the high-risk RCC patients requiring systemic therapy.